By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biodesix, Inc. 

2970 Wilderness Place
Suite 100
Boulder  Colorado  80301  U.S.A.
Phone: 303-417-0500 Fax: n/a



Company News
Norgen Biotek Corporation Announces Supply Agreement With Biodesix, Inc. The First EML4-ALK Liquid Biopsy Test With Results In 72-Hours 3/2/2016 6:57:02 AM
Biodesix, Inc. Release: Investigational Blood Test Identifies Patients With Melanoma Who Are More Likely To Have Improved Survival On Nivolumab Therapy 11/3/2015 7:41:49 AM
Biodesix, Inc. Adds Biognosys’ Proteomics Technology To Its Diagnostic Development Capabilities 7/29/2015 11:18:33 AM
Health Net, Inc. Provides Coverage For Biodesix, Inc.’ Veristrat Test 7/13/2015 8:10:49 AM
Biodesix, Inc. Raises Another $11M 6/23/2015 8:32:32 AM
Biodesix, Inc. Launches GeneStrat Targeted Liquid Biopsy Mutation Test For Patients With Advanced Lung Cancer 5/21/2015 2:47:23 PM
United Healthcare Approves Coverage For Biodesix, Inc.’ VeriStrat Test 5/12/2015 7:56:19 AM
Biodesix, Inc. Release: Lung Cancer Journal: VeristratProteomic Test Improves Overall Survival And Decreases Medical Costs For Patients With Advanced NSCLC 3/24/2015 11:07:23 AM
Biodesix, Inc. And Inivata To Investigate Clinical Utility Of Next Generation Sequencing-Blood Based Tests For Patients With Advanced Lung Cancer 3/11/2015 8:59:51 AM
Biodesix, Inc. Builds On Investments In Sales, Reimbursement And Government Affairs Growth Strategy 2/18/2015 10:52:18 AM